Lack of Marburg Virus Transmission from Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S109-S118

  Paweska, Janusz T ^a,b,d   Van Vuren, Petrus Jansen ^a,d   Fenton, Karla A ^f   Graves, Kerry ^f   Grobbelaar, Antoinette A ^a   Moolla, Naazneen ^a   Leman, Patricia ^a   Weyer, Jacqueline ^a,d   Storm, Nadia ^a   McCulloch, Stewart D ^d   Scott, Terence P ^d   Markotter, Wanda ^d   Odendaal, Lieza ^e   Clift, Sarah J ^e   Geisbert, Thomas W ^f   Hale, Martin J ^b,c   Kemp, Alan ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d Department of Microbiology and Plant Pathology ^*  (South Africa)

^e UNIVERSITY OF PRETORIA   (South Africa)

^f University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Egyptian fruit bat; experimental infection; horizontal transmission; Marburg virus; shedding

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAT; CONTROLLED STUDY; FEMALE; LIVER; MALE; MARBURG HEMORRHAGIC FEVER; NONHUMAN; PRIORITY JOURNAL; ROUSETTUS AEGYPTIACUS; SEROCONVERSION; TISSUE DISTRIBUTION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BLOOD; DISEASE PREDISPOSITION; EPIDEMIC; GENETICS; HUMAN; IMMUNOLOGY; MARBURGVIRUS; PATHOGENICITY; TRANSMISSION; VIROLOGY;

ANIMALS; CHIROPTERA; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MARBURG VIRUS DISEASE; MARBURGVIRUS; VIRUS REPLICATION;

EID: 84943253383     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv132     Document Type: Article

References (24)

1. Swanepoel R, Smit SB, Rollin PE, et al. Studies of reservoir hosts for Marburg virus. Emerg Infect Dis 2007; 13:1847-51.
2. Towner JS, Pourrut X, Albarino CG, et al. Marburg virus infection detected in a common African bat. PLoS One 2007; 2:e764.
3. Pourrut X, Souris M, Towner JS, et al. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect Dis 2009; 9:159.
4. Towner JS, Amman BR, Sealy TK, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5: e1000536.
5. Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:1377-81.
6. Timen A, Koopmans MP, Vossen AC, et al. Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerg Infect Dis 2009; 15:1171-75.
7. Kuzmin I, Niezgoda M, Franka R, et al. Marburg virus in fruit bat, Kenya. Emerg Infect Dis 2010; 16:352-4.
8. Amman BR, Carroll SA, Reed ZD, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog 2012; 8: e1002877.
9. Paweska JT, Jansen van Vuren P, Masumu J, et al. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with Vero cells-adapted Hogan strain of Marburg virus. PLoS One 2012; 7: e45479.
10. Amman BR, Jones MEB, Sealy T, et al. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 2015; 51:113-24.
11. Rippey JJ, Schepers NJ, Gear JH. The pathology of Marburg virus disease. S Afr Med J 1984; 66:50-4.
12. Paweska JT, Jansen van Vuren P, Swanepoel R. Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans. J Virol Methods 2007; 146:119-24.
13. Spencer LT, Bancroft JD. Tissue processing. In: Survana SK, Layton C, Bancroft JD, eds. Bancroft's theory and practice of histological techniques. Churchill Livingstone Elsevier, 2012:106-23.
14. Bancroft JD, Layton C. The hematoxylins and eosin. In: Survana SK, Layton C, Bancroft JD, eds. Bancroft's theory and practice of histological techniques. Churchill Livingstone Elsevier, 2012:173-86.
15. Steele KE, Anderson AO, Mohamadzadeh M. Fibroblastic reticular cell infection by hemorrhagic fever viruses. Immunotherapy 2009; 1:87-97.
16. Simpson DI, Zlotnik I, Rutter DA. Vervet monkey disease: experimental infection of guinea pigs and monkeys with the causative agent. Br J ExpPathol 1968; 49:458-64.
17. Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, et al. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 2007; 196: S372-81.
18. Hensley LE, Alves A, Geisbert JB, Fritz EA, Reed C, Geisbert TW. Pathogenesis of Marburg haemorrhagic fever in cynomolgus macaques. J Infect Dis 2011; 204:S1021-31.
19. Zlotnik I. Marburg agent disease: pathology. Trans R Soc Trop Med Hyg 1969; 63:310-27.
20. Murphy FA, Simpson DI, Whitfield SG, Zlotnik I, Carter GB. Marburg virus infection in monkeys: ultrastructural studies. Lab Invest 1971; 24:279-91.
21. Geisbert TW, Jaax NK. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct Pathol 1998; 22:3-17.
22. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top MicrobiolImmunol 1999; 235:97-116.
23. Martin GA. Marburg agent disease in man. Trans R Soc Trop Med Hyg 1969; 63:295-302.
24. Rodriguez LL, de Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179:S170-6.